Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
X4 Pharmaceuticals, Inc. (XFOR) had Weighted-Average Shares Outstanding (Diluted) of 6.70M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$1.43M |
|
$-39.82M |
|
$0.30M |
|
$1.13M |
|
$37.15M |
|
$-35.72M |
|
$-3.85M |
|
$-39.56M |
|
$-39.56M |
|
$-39.82M |
|
$-39.82M |
|
$-39.82M |
|
$-39.82M |
|
$-35.72M |
|
$-35.44M |
|
6.70M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
6.70M |
$-6.01 |
|
$-6.01 |
|
| Balance Sheet Financials | |
$112.17M |
|
$0.78M |
|
$34.27M |
|
$146.45M |
|
$32.88M |
|
$75.42M |
|
$91.42M |
|
$124.30M |
|
$22.15M |
|
$-5.20M |
|
$22.15M |
|
5.69M |
|
| Cash Flow Statement Financials | |
$-130.90M |
|
$66.99M |
|
$20.29M |
|
$100.25M |
|
$56.48M |
|
$-43.77M |
|
$8.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.41 |
|
-- |
|
-- |
|
0.77 |
|
3.41 |
|
78.94% |
|
-2490.59% |
|
-2490.59% |
|
-- |
|
-2758.93% |
|
-2776.92% |
|
$-26.23M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.11 |
|
0.84 |
|
107.32 |
|
-179.79% |
|
765.50% |
|
-27.19% |
|
-40.81% |
|
$3.89 |
|
$-3.92 |
|
$-19.55 |
|